dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate

C60H70BBrF4K2N8O9 — CID 160847049

IUPACdipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate
SMILESC.CC1(C)OB(c2cccc3nc(C4=CCOCC4)c(C(F)F)cc23)OC1(C)C.CC1C(=O)N(C)Cc2c(-c3cccc4nc(C5=CCOCC5)c(C(F)F)cc34)nc(C3CC3)n21.CC1C(=O)N(C)Cc2c(Br)nc(C3CC3)n21.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C26H26F2N4O2.C21H24BF2NO3.C11H14BrN3O.CH2O3.CH4.2K.H/c1-14-26(33)31(2)13-21-23(30-25(32(14)21)16-6-7-16)17-4-3-5-20-18(17)12-19(24(27)28)22(29-20)15-8-10-34-11-9-15;1-20(2)21(3,4)28-22(27-20)16-6-5-7-17-14(16)12-15(19(23)24)18(25-17)13-8-10-26-11-9-13;1-6-11(16)14(2)5-8-9(12)13-10(15(6)8)7-3-4-7;2-1-4-3;;;;/h3-5,8,12,14,16,24H,6-7,9-11,13H2,1-2H3;5-8,12,19H,9-11H2,1-4H3;6-7H,3-5H2,1-2H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1
InChIKeyRJJFRXCSACCXGF-UHFFFAOYSA-M
MW1292.17 g/mol
LogP4.77
Rot. Bonds9

About dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate

dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate (PubChem CID 160847049) has the molecular formula C60H70BBrF4K2N8O9 and a molecular weight of 1292.17 g/mol. Its IUPAC name is dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate.

Molecular Properties

Compound Namedipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate
PubChem CID160847049
Molecular FormulaC60H70BBrF4K2N8O9
Molecular Weight1292.17 g/mol
Exact Mass1290.38
IUPAC Namedipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate
SMILESC.CC1(C)OB(c2cccc3nc(C4=CCOCC4)c(C(F)F)cc23)OC1(C)C.CC1C(=O)N(C)Cc2c(-c3cccc4nc(C5=CCOCC5)c(C(F)F)cc34)nc(C3CC3)n21.CC1C(=O)N(C)Cc2c(Br)nc(C3CC3)n21.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C26H26F2N4O2.C21H24BF2NO3.C11H14BrN3O.CH2O3.CH4.2K.H/c1-14-26(33)31(2)13-21-23(30-25(32(14)21)16-6-7-16)17-4-3-5-20-18(17)12-19(24(27)28)22(29-20)15-8-10-34-11-9-15;1-20(2)21(3,4)28-22(27-20)16-6-5-7-17-14(16)12-15(19(23)24)18(25-17)13-8-10-26-11-9-13;1-6-11(16)14(2)5-8-9(12)13-10(15(6)8)7-3-4-7;2-1-4-3;;;;/h3-5,8,12,14,16,24H,6-7,9-11,13H2,1-2H3;5-8,12,19H,9-11H2,1-4H3;6-7H,3-5H2,1-2H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1
InChIKeyRJJFRXCSACCXGF-UHFFFAOYSA-M
XLogP4.77
TPSA188.32 Ų
H-Bond Donors
H-Bond Acceptors15
Rotatable Bonds9
Heavy Atoms85
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001292.17
LogP ≤ 54.77
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Analyze dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?
The IUPAC name of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate (CID 160847049) is dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate.
What is the SMILES notation for dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?
The canonical SMILES for dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate is C.CC1(C)OB(c2cccc3nc(C4=CCOCC4)c(C(F)F)cc23)OC1(C)C.CC1C(=O)N(C)Cc2c(-c3cccc4nc(C5=CCOCC5)c(C(F)F)cc34)nc(C3CC3)n21.CC1C(=O)N(C)Cc2c(Br)nc(C3CC3)n21.O=CO[O-].[H-].[K+].[K+].
What is the InChIKey of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?
The InChIKey is RJJFRXCSACCXGF-UHFFFAOYSA-M. The full InChI is InChI=1S/C26H26F2N4O2.C21H24BF2NO3.C11H14BrN3O.CH2O3.CH4.2K.H/c1-14-26(33)31(2)13-21-23(30-25(32(14)21)16-6-7-16)17-4-3-5-20-18(17)12-19(24(27)28)22(29-20)15-8-10-34-11-9-15;1-20(2)21(3,4)28-22(27-20)16-6-5-7-17-14(16)12-15(19(23)24)18(25-17)13-8-10-26-11-9-13;1-6-11(16)14(2)5-8-9(12)13-10(15(6)8)7-3-4-7;2-1-4-3;;;;/h3-5,8,12,14,16,24H,6-7,9-11,13H2,1-2H3;5-8,12,19H,9-11H2,1-4H3;6-7H,3-5H2,1-2H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1.
What are the key properties of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?
dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate has a molecular weight of 1292.17 g/mol, XLogP of 4.77, 9 rotatable bonds, 0 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate is sourced from PubChem (CID 160847049), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).